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development of brown bowel syndrome, which is seen
as the expression of lipofuscinosis of the bowel, and can 
cause further clinical disorders. Patients with malabsorption 
should therefore be monitored regarding their vitamin E 
levels.  © 2014 S. Karger AG, Basel 
 Introduction 
 Chronic long-term or severe malabsorption can be the 
cause of a recurring or persisting deficiency in proteins, 
lipids, electrolytes, vitamins, and other trace elements. In 
particular, a deficit in fat-soluble vitamins such as vitamin 
A, D, E, and K is associated with symptoms of dry skin, 
concentration disorders, fatigue, poor wound healing, co-
agulatory disorders, increased susceptibility to infection, 
and other cognitive and neurological deficits  [1] . The 
main function of vitamin E (tocopherol) as an antioxi-
dant membrane lipid is to guard against auto-oxidation 
or pathological oxidation induced by free radicals; thus, a 
deficiency in this vitamin causes damage to the phospho-
lipid layer of the mitochondrial membrane via free radi-
cals with the resulting development of lipofuscin deposits 
 [2] . Such a deficiency is also associated with an increase 
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 Abstract 
 Background/Aims: Longtime chronic malabsorption may 
among other things cause a lack of liposoluble vitamins. Vi-
tamin E deficiency can lead to formation of lipofuscin ag-
gregates. Its deficiency is also associated with an increased 
lipofuscinosis of the bowel, i.e. brown bowel syndrome. 
 Methods: Systematic research via Medline on brown bowel 
syndrome, lipofuscinosis, and vitamin E deficiency was per-
formed. We combined our own clinical experience and a re-
view of the literature for this paper. Its goal is to inform 
about the possible consequences of severe malabsorption 
and brown bowel syndrome.  Results: Systematic data about 
the occurrence of severe malabsorption and brown bowel 
syndrome are rare. Only about 27 scientific reports can be 
found on this subject. Brown bowel syndrome is found 
mostly in conjunction with vitamin E deficiency and lipofus-
cinosis of the bowel. The clinical findings are caused by both 
malabsorption and lipofuscinosis. Case reports show a ther-
apeutic effect of vitamin E.  Conclusion: Vitamin deficiency 
caused by longtime chronic malabsorption can lead to the 
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in lipofuscinosis of the bowel, i.e. brown bowel syndrome 
 [3, 4] .
 The aim of this study is to familiarize the reader more 
closely with the symptoms and complications of brown 
bowel syndrome as the result of an underlying malab-
sorption disorder. We present the results of a literature 
search and our own clinical experience.
 Definition of Brown Bowel Syndrome 
 Brown bowel syndrome was first reported in the lit-
erature in 1963 and signifies lipofuscinosis mainly in the 
small bowel that is characterized macroscopically by an 
orange-brown appearance  [5] ( fig. 1 ). In addition to the 
atrophic villi that can be viewed microscopically as a sign 
of an underlying malabsorptive disorder, a brown color-
ing particularly of the apical enterocytes demonstrates 
the increased lipofuscin deposits ( fig. 2 ).
 These lipofuscin aggregates are found inside the cell, 
mainly in the smooth muscle cells of the muscular coat, 
but also in the muscular layer of the mucosa  [6–9] . Where-
as more lipofuscin accumulates in the heart, liver tissue, 
and adrenal glands with aging, the mechanism underly-
ing its development has not yet been determined. It is 
thought to be a degradation product of degenerating mi-
tochondria, and in advanced brown bowel syndrome it 
has also been detected – though rarely – in other organs, 
such as the thyroid or intestinal lymph nodes  [3, 8, 10, 11] . 
Other authors have suggested that autophagocytotic pro-
cesses may represent a model for the formation of lipo-
fuscin  [6–8] .
 Presumed Pathogenesis and Clinical Symptoms 
 The cause of this particular form of lipofuscinosis, one 
that is associated with brown coloration in the small bow-
el, has not been elucidated yet. It is generally thought to 
be due to chronic vitamin E deficiency, which is the result 
of deficient enteral uptake of fat-soluble tocopherol in 
malabsorption syndromes such as celiac disease  [12–14] . 
 Deficiencies of a range of nutrients, including vitamin 
E, are a common complication following malabsorptive 
forms of obesity surgery. Indeed, brown bowel syndrome 
was recently reported in a patient in whom a jejunoileal 
bypass had been created 26 years previously  [2] . So even 
a ‘jejunoileal bypass’ as an unusual old procedure may be 
associated with brown bowel syndrome  [2] . Over the 
course of time the vitamin E deficiency or lipofuscinosis 
may cause neuronal functional disorders that, as a result, 
affect bowel motility to a considerable degree  [15] . 
 Advanced brown bowel syndrome presents several 
symptoms in addition to the signs of the underlying mal-
absorption disorder. This includes general dystrophia, 
weight loss, protein deficiency edema, motility problems 
(e.g. vomiting, flatulence, and pseudo-obstructions), liver 
cirrhosis, signs of vitamin deficiency involving severe os-
 Fig. 1. Small bowel preparation of brown bowel syndrome after 20 
years of long-standing malabsorption in congenital intestinal
lymphangiectasia. Mucosal surface and various tissue layers (mus-
cularis propria) are characterized macroscopically by an orange-
brown appearance as a sign of diffuse intestinal lipofuscinosis. 
 Fig. 2. Histological section from jejunal mucosa with villous reduc-
tion and atrophy in chronic malabsorption with brown bowel syn-
drome. Of note are apical enterocytes which contain moderate 
brown inclusions as a sign of lipofuscin aggregates.  
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teoporosis, abdominal pain, diarrhea, and steatorrhea 
 [11, 16] .
 Complications such as electrolytic shift, protein and 
nutrient deficiency with resulting cachexia, and increased 
susceptibility to infection can develop from severe mal-
absorption. They can also be the result of morphological 
changes in the affected bowel segment such as bowel ato-
nia, intussusception, and intestinal pseudo-obstruction 
or gastrointestinal bleeding  [4, 7, 17–20] . Such complica-
tions can be fatal.
 Association with Malignant Diseases 
 The concomitant presentation of brown bowel syn-
drome and carcinoma in the small intestine has only been 
reported in one isolated case so far  [18] . However, brown 
bowel syndrome has been reported to arise concomitant-
ly with other gastrointestinal adenocarcinomas more fre-
quently, but precise data are still lacking because of its 
rarity  [21–23] . 
 According to current data, it is difficult in general to 
determine whether the disease underlying the brown 
bowel syndrome is responsible for the increased risk of 
carcinoma in patients with celiac disease and chronic 
pancreatitis. In other words, it is not known whether the 
chronic inflammation alone contributes to neoplastic 
progression or whether the vitamin E deficiency resulting 
from chronic malabsorption is responsible for this  [23] .
 Other Diseases Associated with Brown Bowel 
Syndrome 
 Table 1 presents several diseases in which the develop-
ment of brown bowel syndrome has been reported. 
 In some studies, a pronounced vitamin E deficiency 
has been discovered, which could help explain the asso-
ciation with brown bowel syndrome. To date, however, a 
prospective observation of decreased vitamin E levels to 
development of the brown bowel syndrome has not yet 
been established in humans. Following malabsorptive 
techniques of obesity surgery (in particular biliopancre-
atic diversion), vitamin E deficiency is common. Screen-
ing and appropriate supplementation (not only of vita-
min E deficiency, but also of a wide range of other macro- 
and micronutrients) are therefore a crucial aspect of 
routine long-term follow-up  [2] .
 Brown bowel syndrome has mainly been found to be 
associated with malabsorptive disorders of the small bow-
el, such as celiac disease and intestinal lymphoma  [4, 23, 
24] . Furthermore, an association between congenital 
bowel malformations such as small intestinal atresia has 
also been established  [26] .
 Lipofuscin aggregates have also been discovered in the 
smooth muscle cells of the muscular layer of the mucosa 
in patients with chronic inflammatory bowel diseases 
such as Crohn’s disease and in severe cases of ulcerative 
enteritis  [7, 27] . In one case report, brown bowel syn-
drome developed in a patient with known Crohn’s disease 
within 5 years  [27] . Here, the typical lipofuscin deposits 
were found in the cytoplasm and in the perinuclear re-
gions of the smooth muscle cells, which gave rise to the 
notion that brown bowel syndrome might possibly be a 
‘mitochondrial myopathy’. The loss of mitochondrial 
function and resulting disorder in energy production ul-
timately causes atrophy and atonia of the smooth muscle 
 [3, 4] . In fact, the damage to the smooth muscle of the 
bowel present in existing brown bowel syndrome can ex-
plain many functional symptoms or pathophysiological 
findings, including bowel atonia, intussusception, intes-
Table 1.  Summary of diseases associated with or predisposing to 
the development of brown bowel syndrome
Keynotes Example Reference
Malabsorption celiac disease [14, 28] 
Maldigestion chronic pancreatitis [23]
liver disease, cholestasis [11]
















Postoperative conditions obesity surgery
jejunoileal bypass
[2]
Vitamin E deficiency α-β-lipoproteinemia [30]






tinal pseudo-obstruction, various anorectal functional 
disturbances, etc.  [4, 7, 17] .
 Exocrine pancreas insufficiency can cause inadequate 
resorption of fat-soluble vitamins (vitamins A, D, E, and 
K)  [31, 32] . Chronic vitamin E deficiency can then induce 
brown bowel syndrome  [12, 13] .
 Likewise, severe malabsorption syndrome and celiac 
disease are also both associated with chronic vitamin E 
deficiency, which in turn produces the lipofuscin aggre-
gates typical for brown bowel syndrome and the macro-
scopically apparent brown coloration of the small bowel. 
Indeed, a case report was published concerning a patient 
in whom radiologically visible changes were detected that 
were similar to those observed in intestinal lymphoma 
 [24] . Histologically, brown bowel syndrome was con-
firmed in this patient by a transmural biopsy taken from 
a segment of the small bowel in which a brown coloration 
had been observed. The authors postulate that the lipo-
fuscin deposits in the muscular layer of the mucosa caused 
the changes that could be detected radiologically and 
which are similar to the radiological changes observed for 
intestinal lymphoma  [24] .
 Micronutrient metabolism deficiency can also be 
caused by various other malabsorption syndromes. Here, 
the liver should be mentioned in particular, as it is the 
organ primarily responsible for metabolism. Via biliary 
secretion, the liver regulates fat digestion and the absorp-
tion of fat-soluble vitamins. In the literature, case reports 
can be found of patients with liver cirrhosis and resulting 
malabsorption and brown bowel syndrome  [11] . How-
ever, no studies have been performed in which serum vi-
tamin E levels were correlated with the extent of nutri-
tional deficiency and the development of brown bowel 
syndrome.
 One case study reported massive bleeding in the lower 
gastrointestinal tract in conjunction with the presence of 
brown bowel syndrome  [20] . The authors postulated that 
the functional loss of the mitochondria in the smooth 
muscle cells, which is typical for this disease, contributed 
to or caused the bleeding. Histologically, lipofuscin de-
posits were demonstrated in the smooth muscle cells of 
the arterial and venous walls, which ultimately caused 
hemorrhagia and persistent bleeding  [20] .
 Diagnosis and Treatment 
 Among many other serological parameters (e.g. C-re-
active protein, albumin, total protein, transglutaminase 
IgA, etc.), serum levels of fat-soluble vitamins and carot-
enoids are determined for the diagnosis of malabsorptive 
disorders. In addition, the fat content in stool samples can 
be measured to gain further information. Imaging proce-
dures (abdominal ultrasound, MRI, barium enema, and 
CT) and endoscopic examinations including multiple bi-
opsies from the small bowel should also be performed.
 The term vitamin E constitutes a collective name for 
all natural and synthetic tocol and tocotrienol derivatives, 
which qualitatively demonstrate the biological activity of 
α-tocopherol  [33, 34] . Tocopherol is the umbrella term 
for all mono-, di-, and trimethyl tocotrienols. To deter-
mine the levels of the individual tocopherols, high-per-
formance liquid chromatography, gas chromatography, 
and the combined techniques high-performance liquid 
chromatography-mass spectrometry and gas chromatog-
raphy-mass spectrometry are employed  [33, 34] . Further 
studies in this area would be desirable to more precisely 
distinguish the actual vitamin E deficiency in the various 
conditions by measuring serum levels in patients with 
malabsorptive disorders (celiac disease, chronic pancre-
atitis, and chronic inflammatory bowel diseases), motil-
ity disorders (recurrent pseudo-obstruction, myopathy), 
and in patients with chronic atresia or atonia and after 
bariatric surgery  [2, 7] .
 In this context, we still need to clarify what role quan-
titative serum vitamin E levels play (cutoff values for the 
development of brown bowel syndrome). For the patho-
logical diagnosis based on small bowel biopsy, it is impor-
tant to know that lipofuscin often cannot be detected with 
certainty by using conventional hematoxylin-eosin stain-
ing. Therefore, if brown bowel syndrome is suspected, e.g. 
in conjunction with recurring motility disorders of thus 
far unexplained etiology or when a brown-golden color-
ation of the small bowel is apparent endoscopically or 
macroscopically (differential diagnosis Whipple disease), 
the pathologist should be informed accordingly about 
these particular findings. Further specialized histological 
examinations can then be performed to confirm or ex-
clude the presence of this disease. Here, supplementary 
UV light microscopy is mainly applied or electron mi-
croscopy is used for evaluation  [9, 35] .
 Several authors have reported for confirmed brown 
bowel syndrome that long-term vitamin supplementa-
tion improved the malabsorption syndrome and was ac-
companied by regression of the lipofuscin deposits  [26] . 
The required daily dose of vitamin E for brown bowel 
syndrome depends on the serum levels of vitamin, clinical 
symptoms, and supply of polyunsaturated fatty acids. 
Generally, the dose of vitamin E for therapeutic substitu-
tion lies between 250 and 1,000 IU of vitamin E (corre-
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sponding to 150–600 mg per day). For comparison, the 
dose of vitamin E for prophylactic supplementation for 
adults is 20–35 mg per day.
 Conclusion 
 Diseases involving chronic severe malabsorption are 
rare; however, they can develop in individual cases of re-
fractory small bowel disease, advanced chronic pancreati-
tis, or liver diseases, result from a lack of vitamin E, or also 
develop as a complication of malabsorptive bariatric sur-
gery. These conditions are also associated with the risk of 
brown bowel syndrome, which in turn induces further 
disease symptoms, recurring motility disorders, and diar-
rhea. Therefore, for the treatment of malabsorption syn-
dromes and diseases of the liver and pancreas, the devel-
opment of brown bowel syndrome associated with the 
aforementioned symptoms should be considered for dif-
ferential diagnosis in order to initiate treatment with vi-
tamin E supplementation and/or other fat-soluble vita-
mins in a timely manner.
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